G-Technology

G42, OceanX, G-Tech and the Indonesian Government to Collaborate to Advance Oceanic Research to Protect the Marine Environment

Retrieved on: 
Friday, November 18, 2022
Environment, Technology, Drones, Audio, Video, Software, Green Technology, Hardware, Data Management, Artificial Intelligence, Biodiversity, AI, Letter, Government, G-Technology, Ministry of Maritime Affairs, Transport and Infrastructure, Letter of intent, Defense, Maritime resource management, Welfare, Cloud computing, Molecular medicine, Science, Research, Energy, HAPS, Republic, Ministry, Travel, Bayanat, Climate, Transport, OceanX, ADX, Renewable energy, Aquaculture, Management, Risk management, Environment, Dalio, G42

The project recognizes the importance of detailed mapping of marine resources through advanced technologies in order to protect and preserve the ocean environment and the livelihoods of the communities that are reliant on it.

Key Points: 
  • The project recognizes the importance of detailed mapping of marine resources through advanced technologies in order to protect and preserve the ocean environment and the livelihoods of the communities that are reliant on it.
  • G42 will support OceanX and CMMAI research with a focus on mapping fisheries and marine resources through data-driven e-DNA, socio-economic, and ecological characters in coastal-marine ecosystems.
  • The proposed collaboration also includes training and knowledge transfer to build human capacity and supporting infrastructure for CMMAI.
  • Its offering includes topographic, hydrographic and aeronautical products and charts, as well as spatial data surveying, analysis, management, modelling, visualization and cartography services.

ENOCHIAN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Sunday, September 25, 2022
Class Action Lawsuit, Professional Services, Legal, Seraph, Central District, Risk, U.S. Department of Justice Office of Legislative Affairs, Coronavirus, Justice, LLC, Company, News, P.C, For Hire, Person, Office of Inspector General, U.S. Department of Health and Human Services, Lists of schools in England, Cancer, Hindenburg, Hepatitis B virus, Technology, HIV, Defendant, Jeanne Eagels, Science, SRI, Fraud, Court, NASDAQ, China Biologic Products, Telephone, District court, G-Technology, Hindenburg Research, Identity theft, Private investigator, Renewable energy, Pharmaceutical industry, Enochian

Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, September 21, 2022
Seraph, Securities Exchange Act of 1934, Complaint, Central District, Risk, U.S. Department of Justice Office of Legislative Affairs, Coronavirus, Justice, LLC, Company, Pomerantz, News, Lists of action films, For Hire, Person, Office of Inspector General, U.S. Department of Health and Human Services, LLP, Cancer, Lists of schools in England, Hindenburg, Hepatitis B virus, Technology, HIV, SEC Rule 10b-5, Defendant, Science, SRI, Fraud, Court, NASDAQ, China Biologic Products, District court, Ext, G-Technology, GLOBE, Hindenburg Research, Identity theft, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bronstein, Gewirtz & Grossman, LLC Reminds Enochian Biosciences Inc. (ENOB) Investors of Class Action and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, September 21, 2022
Complaint, LLC, Company, Review, Person, Lists of schools in England, Defendant, Fraud, SRI, Court, NASDAQ, GLOBE, G-Technology, Private investigator, Enochian

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/enob .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/enob .
  • The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Thursday, September 15, 2022
Seraph, Securities Exchange Act of 1934, Complaint, Central District, U.S. Department of Justice Office of Legislative Affairs, Coronavirus, Justice, LLC, Company, Pomerantz, News, Lists of action films, For Hire, Person, Office of Inspector General, U.S. Department of Health and Human Services, LLP, Cancer, Lists of schools in England, Hindenburg, Hepatitis B virus, Technology, HIV, SEC Rule 10b-5, Defendant, Science, SRI, Fraud, Court, NASDAQ, China Biologic Products, District court, Ext, G-Technology, GLOBE, Hindenburg Research, Identity theft, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Edelson Lechtzin LLP Notifies Enochian Biosciences, Inc. Investors of a Class Action Lawsuit

Retrieved on: 
Friday, September 9, 2022
Office of Inspector General, U.S. Department of Health and Human Services, HIV, Cancer, Hepatitis B virus, G-Technology, District court, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, LLP, Lists of schools in England, China Biologic Products, Hindenburg Research, Coronavirus, Felony, Theft, ERISA, Central District, Complaint, Lawyer, SRI, GLOBE, Company, Douglas v. U.S. District Court ex rel Talk America, News, Fraud, Risk, Hindenburg, Pharmaceutical industry, Enochian

Investors who purchased Enochian Biosciences common stock during the Class Period may move the U.S. District Court for the Central District of California to appoint them as lead plaintiff, no later than September 26,2022.

Key Points: 
  • Investors who purchased Enochian Biosciences common stock during the Class Period may move the U.S. District Court for the Central District of California to appoint them as lead plaintiff, no later than September 26,2022.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • Investors who wish to discuss the lead plaintiff selection process should contact Edelson Lechtzin LLP, toll free at 1-844-696-7492, or by email at [email protected] .
  • Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Tuesday, September 6, 2022
Seraph, Ext, Lists of action films, HIV, Technology, Office of Inspector General, U.S. Department of Health and Human Services, Cancer, Securities Exchange Act of 1934, SEC Rule 10b-5, Hepatitis B virus, G-Technology, District court, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, LLP, Lists of schools in England, Person, China Biologic Products, Hindenburg Research, Coronavirus, Identity theft, Defendant, Science, Court, Central District, Complaint, SRI, GLOBE, Company, Justice, News, LLC, Fraud, Pomerantz, For Hire, Hindenburg, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

TGTX, YQ & ENOB Class Actions Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Reminds Investors to Contact the Firm and Actively Participate

Retrieved on: 
Thursday, September 1, 2022
Complaint, YQ, NDA, Prospectus, Survival, G-Technology, Register, Education, NASDAQ, Lists of schools in England, Overalls, IPO, Defendant, Court, Academy, SRI, GLOBE, Registration statement, Company, FDA, LLC, Fraud, U2, Pharmaceutical industry, Public relations, Umbralisib, Ublituximab

You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.

Key Points: 
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
  • The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Tuesday, August 30, 2022
Seraph, Ext, Lists of action films, HIV, Technology, Office of Inspector General, U.S. Department of Health and Human Services, Cancer, Securities Exchange Act of 1934, SEC Rule 10b-5, Hepatitis B virus, G-Technology, District court, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, LLP, Lists of schools in England, Person, China Biologic Products, Hindenburg Research, Coronavirus, Identity theft, Defendant, Science, Court, Central District, Complaint, SRI, GLOBE, Justice, Company, News, LLC, Fraud, Pomerantz, Risk, For Hire, Hindenburg, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, August 24, 2022
Seraph, Ext, Lists of action films, HIV, Technology, Office of Inspector General, U.S. Department of Health and Human Services, Cancer, Securities Exchange Act of 1934, SEC Rule 10b-5, Hepatitis B virus, G-Technology, District court, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, LLP, Lists of schools in England, Person, China Biologic Products, Hindenburg Research, Coronavirus, Identity theft, Defendant, Science, Court, Central District, Complaint, SRI, GLOBE, Justice, Company, News, LLC, Fraud, Pomerantz, Risk, For Hire, Hindenburg, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.